KOSPI, Afternoon Sees Narrowing Gains
[Asia Economy Reporter Minji Lee] The KOSPI, which had risen nearly 1% during the session, is narrowing its gains in the afternoon.
As of 1:53 PM on the 25th, the KOSPI stood at 2,988.99, up 0.09% (2.64 points) from the previous trading day. The KOSPI opened at 2,995.67, down 0.02% (0.68 points) from the previous day, and climbed to as high as 3,024.63 during the session. Looking at investor trends, individual investors bought stocks worth 193.2 billion KRW alone, while foreigners and institutions sold stocks worth 119.7 billion KRW and 62.8 billion KRW, respectively.
Among the top market capitalization stocks, Samsung Electronics (0.37%) and Samsung Biologics (0.42%) rose, while SK Hynix (-1.12%), Naver (-2%), Hyundai Motor (-1.36%), and Samsung SDI (-0.31%) declined.
At the same time, the KOSDAQ index stood at 951.15, down 0.28% (2.67 points) from the previous trading day. The KOSDAQ opened at 953.26, down 0.06% (0.56 points) from the previous day. In terms of investor activity, individual investors were net buyers of stocks worth 144 billion KRW, while foreigners and institutions sold stocks worth 121.4 billion KRW and 13.9 billion KRW, respectively.
Among the top market capitalization stocks, Celltrion Pharm (-0.54%), Seegene (-1.18%), SK Materials (-1.42%), and CJ ENM (-0.28%) declined.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Seosangyoung, a researcher at Kiwoom Securities, explained, “Although the market fell due to the sluggish U.S. stock market, the Chinese stock market showed resilience with a rebound, leading to a nearly 1% rise during the session. However, just before the morning session closed, the decline in the Chinese stock market and the downward revision of AstraZeneca’s clinical trial results affected the narrowing of the KOSPI’s gains.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.